Rare diseases
Investigational molecules
Locations
Back to Belgium1 129 clinical trials in Leuven, Belgium across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study of felzartamab compared to placebo in adults with IgA nephropathy
BelgiumStudy of MK-2214 to slow disease progression in people with early Alzheimer's disease
BelgiumStudy of Zolbetuximab combined with Paclitaxel and Ramucirumab for patients with previously treated CLDN18.
BelgiumComparing diclofenac sodium eye drops versus dexamethasone phosphate eye drops for recovery after vitrectomy in patients with macular disorders
BelgiumStudy of telisotuzumab adizutecan with osimertinib as first treatment for adults with advanced or metastatic EGFR-mutated non-small cell lung cancer
BelgiumStudy of Atacicept Treatment for Patients with Multiple Autoimmune Glomerular Diseases
BelgiumStudy comparing RMC-6236 and docetaxel in previously treated patients with advanced or metastatic non-small cell lung cancer who have RAS mutations
BelgiumStudy of mirvetuximab soravtansine dosing schedules for patients with platinum-resistant advanced ovarian, peritoneal, or fallopian tube cancer with high folate receptor expression
BelgiumStudy of ABBV-453 alone or with drug combination for adults with multiple myeloma: evaluation of safety and effectiveness
BelgiumStudy of sonrotoclax plus obinutuzumab or rituximab compared to venetoclax plus rituximab in patients with relapsed or refractory chronic lymphocytic leukemia
BelgiumStudy of trastuzumab deruxtecan with bevacizumab versus bevacizumab alone as first-line maintenance treatment for patients with HER2-expressing ovarian cancer
BelgiumStudy of datopotamab deruxtecan with platinum-based therapy compared to gemcitabine with platinum-based therapy in patients with advanced urothelial cancer after prior treatment
BelgiumThe busiest research cities in the country
What the registry says about research in the country
Clinical investigations focusing on ulcerative colitis and innovative treatments for inflammatory bowel conditions. Studies include evaluation of novel therapies for short bowel syndrome and gastrointestinal motility disorders.
Current trials are examining drug absorption and therapeutic responses in patients with various digestive conditions.
Groundbreaking research in head and neck cancer treatments, including innovative radiotherapy approaches. Studies are also investigating new therapies for bladder cancer, focusing on early-stage interventions.
Emphasis on combining traditional treatments with novel therapeutic approaches to improve patient outcomes.
Comprehensive studies on Alzheimer's disease and frontotemporal dementia, investigating disease progression and potential treatments. Research includes innovative approaches to understanding brain circuit functionality.
Advanced imaging techniques are being utilized to track disease progression and treatment effectiveness.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
